Friday, October 24, 2014 9:49:23 AM
09:47:52 1.48 200 EDGX
09:47:40 1.48 2000 NDD
09:47:39 1.48 200 EDGX
09:47:39 1.48 12000 NDD
09:47:38 1.479 1000 AMX
09:47:26 1.48 200 EDGX
09:47:14 1.48 200 EDGX
09:47:01 1.48 200 EDGX
09:46:49 1.48 200 EDGX
09:46:36 1.48 100 BATS
09:46:36 1.48 100 BATS
09:46:28 1.48 200 NDD
09:46:28 1.48 400 NDD
09:46:28 1.48 200 NDD
09:46:28 1.48 200 NDD
09:46:28 1.48 100 BATS
09:46:28 1.48 100 BATS
09:46:24 1.48 100 BATS
09:46:24 1.48 100 BATS
09:46:11 1.48 100 BATS
09:46:11 1.48 100 BATS
09:45:58 1.48 100 BATS
09:45:58 1.48 100 BATS
09:45:46 1.48 100 BATS
09:45:46 1.48 100 BATS
09:45:33 1.48 100 BATS
09:45:33 1.48 100 BATS
09:45:21 1.48 100 BATS
09:45:21 1.48 100 BATS
09:45:08 1.48 100 BATS
09:45:08 1.48 100 BATS
09:44:55 1.48 200 BATS
09:44:42 1.48 100 BATS
09:44:42 1.48 100 BATS
09:44:29 1.48 100 BATS
09:44:29 1.48 100 BATS
09:44:17 1.48 100 BATS
09:44:17 1.48 100 BATS
09:44:04 1.48 100 BATS
09:44:04 1.48 100 BATS
09:43:51 1.48 100 BATY
09:43:51 1.48 100 BATY
09:43:39 1.473 100 NDD
09:43:38 1.48 200 BATY
09:43:25 1.48 200 EDGA
09:43:13 1.48 100 BATS
09:43:13 1.48 100 BATS
09:43:00 1.48 200 EDGA
09:42:47 1.48 100 BATS
09:42:47 1.48 100 BATS
Recent CDMO News
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:33:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:32:11 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM